Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

ClinicalTrials.gov ID: NCT02222493

Public ClinicalTrials.gov record NCT02222493. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 3:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-blind Study Assessing The Efficacy And Safety Of Pf-06438179 And Infliximab In Combination With Methotrexate In Subjects With Moderately To Severely Active Rheumatoid Arthritis Who Have Had An Inadequate Response To Methotrexate

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will assess the efficacy and safety of PF-06438179 and infliximab in combination with methotrexate in subjects with active rheumatoid arthritis who have had an inadequate response to methotrexate.

Study identification

NCT ID
NCT02222493
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
650 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 25, 2014
Primary completion
Jun 28, 2016
Completion
May 31, 2017
Last update posted
May 29, 2018

2014 – 2017

United States locations

U.S. sites
43
U.S. states
22
U.S. cities
37
Facility City State ZIP Site status
Achieve Clinical Research, LLC Birmingham Alabama 35216
Clinical and Translational Research Center of Alabama, PC Tuscaloosa Alabama 35406
Sun Valley Arthritis Center, Ltd. Peoria Arizona 85381
Arizona Arthritis & Rheumatology Associates, P.C. Phoenix Arizona 85037
St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare Fullerton California 92835
Arthritis & Osteoporosis Medical Center La Palma California 90623
Inland Rheumatology Clinical Trials, Inc. Upland California 91786
Desert Valley Medical Group Victorville California 92395
Javed Rheumatology Associates, Inc Newark Delaware 19713
Arthritis and Rheumatic Disease Specialties Aventura Florida 33180
International Medical Research Daytona Beach Florida 32117
Not listed Daytona Beach Florida 32117
San Marcus Research Clinic, Inc. Miami Florida 33015
Advance Medical Research Services Corporation Miami Florida 33165
Sarasota Arthritis Research Center Sarasota Florida 34239
Alastair C. Kennedy, MD Vero Beach Florida 32960
Indian River Primary Care Vero Beach Florida 32960
Harbin Clinic Rome Georgia 30165
Advanced Clinical Research Meridian Idaho 83642
Methodist Medical Center of IL Peoria Illinois 61636
Physician's Clinic of Iowa, P.C. Cedar Rapids Iowa 52403
Gilbert-Graves Clinic Bowling Green Kentucky 42101
Graves-Gilbert Clinic Bowling Green Bowling Green Kentucky 42101
Ochsner Clinic Baton Rouge Baton Rouge Louisiana 70809
Arthritis and Diabetes Clinic, Inc. Monroe Louisiana 71203
The Center for Rheumatology and Bone Research Wheaton Maryland 20902
Western Michigan University Homer Stryker MD School of Medicine Center for Clinical Research Battle Creek Michigan 49015
Arthritis, Rheumatic & Back Disease Associates Voorhees Township New Jersey 08043
Trinity Health Center-Medical Arts Minot North Dakota 58701
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Clinical Research Center of Reading, LLC Wyomissing Pennsylvania 19610
Low Country Rheumatology, PA Charleston South Carolina 29406
Regional Health Clinical Research Rapid City South Dakota 57701
Regional Medical Clinic Rapid City South Dakota 57701
West Tennessee Research Institute Jackson Tennessee 38305
Ramesh C Gupta, MD Memphis Tennessee 38119
Austin Regional Clinic Austin Texas 78731
Metroplex Clinical Research Center Dallas Texas 75231
Accurate Clinical Research, Inc. Houston Texas 77034
Accurate Clinical Research Nassau Bay Texas 77058
Pharmacy Services, Sentara Leigh Hospital Norfolk Virginia 23502
Sentara Medical Group, Clinical Research Norfolk Virginia 23502
The Seattle Arthritis Clinic Seattle Washington 98133

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 141 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02222493, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 29, 2018 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02222493 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →